Budget Amount *help |
¥23,660,000 (Direct Cost: ¥18,200,000、Indirect Cost: ¥5,460,000)
Fiscal Year 2017: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2016: ¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2015: ¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2014: ¥8,060,000 (Direct Cost: ¥6,200,000、Indirect Cost: ¥1,860,000)
|
Outline of Final Research Achievements |
In the current study, we have evaluated the ERAP1 allotype in Turkish population. We identified 10 distinct ERAP1 allotypes. Among them, only hap10 conferred strong risk for BD. Hap 10 and HLA-B51 showed significant gene-gene interaction. Expression analysis of CCR1 and IL10 showed high expression of these molecules in M2 macrophages. Skin regions of BD patients showed M1-macrophage predominant inflammation. These results show promise for targeting GWAS-identified genes for treatment strategy for BD.
|